Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 23;8:605744. doi: 10.3389/fcell.2020.605744

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Zhang, Zhao, Li, Fu, Zhang, Fu, Zheng and Zhang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Prognostic value of HHEX in breast cancer (BC) and relationship between HHEX and clinicopathological parameters of BC patients. (A) Kaplan–Meier plotter, GEPIA, TCGAportal, and OncoLnc reveal the prognostic value of HHEX in BC. (a) Kaplan–Meier plotter reveals the overall survival curves based on the mRNA level of HHEX in BC patients. (b) Kaplan–Meier plotter reveals relapse-free survival curves based on the mRNA level of HHEX in BC patients. (c) Overall survival curves of HHEX in BC patients determined using GEPIA. (d) Overall survival curves of HHEX in BC patients determined using TCGAportal. (e) Overall survival curves of HHEX in BC patients determined using OncoLnc. (B) Survival curves based on protein level of HHEX in BC patients determined using HPA. (C) Relationship between mRNA levels of HHEX with subclasses of BC determined using UALCAN. (D) Correlation between HHEX and the pathological stage of BC patients determined using GEPIA. (E) Relationship between mRNA levels of HHEX and clinicopathological parameters of BC patients determined using bc-GenExMiner. **P < 0.05, ***P < 0.001.